These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9338486)

  • 21. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
    Heizmann WR; Schmid R; Heilmann F; Werner H
    Infection; 1989; 17(3):160-4. PubMed ID: 2737759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M; Baysal B
    Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
    Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
    Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibility of bacteria associated with endodontic abscesses.
    Baumgartner JC; Xia T
    J Endod; 2003 Jan; 29(1):44-7. PubMed ID: 12540219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
    Dubreuil L; Devos J; Beerens H; Romond C
    Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
    Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
    Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.
    Sobottka I; Wegscheider K; Balzer L; Böger RH; Hallier O; Giersdorf I; Streichert T; Haddad M; Platzer U; Cachovan G
    Antimicrob Agents Chemother; 2012 May; 56(5):2565-9. PubMed ID: 22354306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates.
    Erwin ME; Fix AM; Jones RN
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):129-32. PubMed ID: 11248527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Loza E; Morosini MI; Cantón R; Almaraz F; Reig M; Baquero F
    Rev Esp Quimioter; 2003 Jun; 16(2):209-15. PubMed ID: 12973459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
    Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
    Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations and in vivo antibacterial activity of spiramycin and metronidazole in patients with periodontitis treated with high-dose metronidazole and the spiramycin/metronidazole combination.
    Poulet PP; Duffaut D; Barthet P; Brumpt I
    J Antimicrob Chemother; 2005 Mar; 55(3):347-51. PubMed ID: 15695539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic combinations of antimicrobial agents against anaerobic bacteria.
    Brook I
    Pediatr Infect Dis J; 1987 Mar; 6(3):332-5. PubMed ID: 3554130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periapical abscesses: causal bacteria and antibiotic sensitivity.
    Goumas PD; Naxakis SS; Papavasiliou DA; Moschovakis ED; Tsintsos SJ; Skoutelis A
    J Chemother; 1997 Dec; 9(6):415-9. PubMed ID: 9491841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease.
    Poulet PP; Duffaut D; Lodter JP
    J Clin Periodontol; 1999 Apr; 26(4):261-3. PubMed ID: 10223399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.